Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL595583 |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
GRB2-associated-binding protein 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4523286] [UniProtKB: Q13480] | ||||||||
ChEMBL | Binding affinity to recombinant human GAB1 PH domain expressed in Escherichia coli BL21 (DE3) by surface plasmon resonance assay | B | 5.88 | pKd | 1330 | nM | Kd | US-20170311597-A1. Inhibitors of grb2-associated binding protein 1 (gab1) and methods of treating cancer using the same (2017) |
AKT serine/threonine kinase 1/RAC-alpha serine/threonine-protein kinase in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5859] [GtoPdb: 1479] [UniProtKB: P31750] | ||||||||
ChEMBL | Displacement of biotinylated phosphatidylinositol-3,4,5-phosphate from mouse AKT1 PH domain by surface plasmon resonance competitive binding assay | B | 5.62 | pKi | 2400 | nM | Ki | Bioorg Med Chem (2011) 19: 2046-2054 [PMID:21353784] |
AKT serine/threonine kinase 1/Serine/threonine-protein kinase AKT in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4282] [GtoPdb: 1479] [UniProtKB: P31749] | ||||||||
ChEMBL | Inhibition of pleckstrin homology domain of AKT by surface plasmon resonance spectroscopy | B | 4.39 | pKd | 40800 | nM | Kd | Bioorg Med Chem (2009) 17: 6983-6992 [PMID:19734051] |
ChEMBL | SPR Competitive Binding Assay: SPR interaction analyses were performed with a Biacore 2000, using Biacore 2000 Control Software v3.2 and BIAevaluation v4.1 analysis software (Biacore) as described in Mol Cancer Ther 7:2621 (2008). For the competitive binding assays and the Ki determination, PtdIns(3,4,5)phosphate-biotin labeled liposomes (Echelon Biosciences) and SA chips were used with increasing concentrations of the compound tested. | B | 4.39 | pKd | 40800 | nM | Kd | US-9320734-B2. Small molecule inhibitors of the pleckstrin homology domain and methods for using same (2016) |
ChEMBL | SPR Competitive Binding Assay: SPR interaction analyses were performed with a Biacore 2000, using Biacore 2000 Control Software v3.2 and BIAevaluation v4.1 analysis software (Biacore) as described in Mol Cancer Ther 7:2621 (2008). For the competitive binding assays and the Ki determination, PtdIns(3,4,5)phosphate-biotin labeled liposomes (Echelon Biosciences) and SA chips were used with increasing concentrations of the compound tested. | B | 4.39 | pKd | 40800 | nM | Kd | US-9320734-B2. Small molecule inhibitors of the pleckstrin homology domain and methods for using same (2016) |
ChEMBL | SPR Competitive Binding Assay: SPR interaction analyses were performed with a Biacore 2000, using Biacore 2000 Control Software v3.2 and BIAevaluation v4.1 analysis software (Biacore) as described in Mol Cancer Ther 7:2621 (2008). For the competitive binding assays and the Ki determination, PtdIns(3,4,5)phosphate-biotin labeled liposomes (Echelon Biosciences) and SA chips were used with increasing concentrations of the compound tested. | B | 4.87 | pKd | 13490 | nM | Kd | US-9320734-B2. Small molecule inhibitors of the pleckstrin homology domain and methods for using same (2016) |
ChEMBL | SPR Competitive Binding Assay: SPR interaction analyses were performed with a Biacore 2000, using Biacore 2000 Control Software v3.2 and BIAevaluation v4.1 analysis software (Biacore) as described in Mol Cancer Ther 7:2621 (2008). For the competitive binding assays and the Ki determination, PtdIns(3,4,5)phosphate-biotin labeled liposomes (Echelon Biosciences) and SA chips were used with increasing concentrations of the compound tested. | B | 4.87 | pKd | 13490 | nM | Kd | US-9320734-B2. Small molecule inhibitors of the pleckstrin homology domain and methods for using same (2016) |
ChEMBL | SPR Competitive Binding Assay: SPR interaction analyses were performed with a Biacore 2000, using Biacore 2000 Control Software v3.2 and BIAevaluation v4.1 analysis software (Biacore) as described in Mol Cancer Ther 7:2621 (2008). For the competitive binding assays and the Ki determination, PtdIns(3,4,5)phosphate-biotin labeled liposomes (Echelon Biosciences) and SA chips were used with increasing concentrations of the compound tested. | B | 5.62 | pKi | 2400 | nM | Ki | US-9320734-B2. Small molecule inhibitors of the pleckstrin homology domain and methods for using same (2016) |
ChEMBL | SPR Competitive Binding Assay: SPR interaction analyses were performed with a Biacore 2000, using Biacore 2000 Control Software v3.2 and BIAevaluation v4.1 analysis software (Biacore) as described in Mol Cancer Ther 7:2621 (2008). For the competitive binding assays and the Ki determination, PtdIns(3,4,5)phosphate-biotin labeled liposomes (Echelon Biosciences) and SA chips were used with increasing concentrations of the compound tested. | B | 5.62 | pKi | 2400 | nM | Ki | US-9320734-B2. Small molecule inhibitors of the pleckstrin homology domain and methods for using same (2016) |
ChEMBL | Binding affinity to AKT1 (unknown origin) by surface plasmon resonance assay | B | 5.62 | pKi | 2400 | nM | Ki | US-20170311597-A1. Inhibitors of grb2-associated binding protein 1 (gab1) and methods of treating cancer using the same (2017) |
ChEMBL | Cellular Assay: Inhibition of AKT was measured by Western blots using specific antibodies against phospho-Ser473-AKT in HT-29 lung cancer cells. Inhibition of the phosphorylation of AKT and its downstream targets was measured by Western blotting using rabbit polyclonal antibodies to phospho-Ser473-AKT, phospho-Thr308-AKT, total-AKT, phospho-Ser9-GSK3β, phospho-Ser21-GSK3β, phospho-Ser241-PDK1 and phospho-Thr389p70S6-kinase (New England Biolabs/Cell Signaling Technology Inc.) using β-Actin as a loading control as described in Mol Cancer Ther 7:2621 (2008). Bands corresponding to phospho-Ser473-AKT and total AKT were quantified using Eagle Eye software (BioRad) and Kodak X-Omat™ Blue XB (NEN™, Life Science Products). Cell growth inhibition was determined using a microcytotoxicity assay and apoptosis was measured as described in Mol Cancer Ther 7:2621 (2008). | B | 5 | pIC50 | 10000 | nM | IC50 | US-9320734-B2. Small molecule inhibitors of the pleckstrin homology domain and methods for using same (2016) |
ChEMBL | Inhibition of Akt phosphorylation in human BxPC3 cells by Western blotting | B | 5.2 | pIC50 | 6300 | nM | IC50 | Bioorg Med Chem (2009) 17: 6983-6992 [PMID:19734051] |
ChEMBL | Cellular Assay: Inhibition of AKT was measured by Western blots using specific antibodies against phospho-Ser473-AKT in HT-29 lung cancer cells. Inhibition of the phosphorylation of AKT and its downstream targets was measured by Western blotting using rabbit polyclonal antibodies to phospho-Ser473-AKT, phospho-Thr308-AKT, total-AKT, phospho-Ser9-GSK3β, phospho-Ser21-GSK3β, phospho-Ser241-PDK1 and phospho-Thr389p70S6-kinase (New England Biolabs/Cell Signaling Technology Inc.) using β-Actin as a loading control as described in Mol Cancer Ther 7:2621 (2008). Bands corresponding to phospho-Ser473-AKT and total AKT were quantified using Eagle Eye software (BioRad) and Kodak X-Omat™ Blue XB (NEN™, Life Science Products). Cell growth inhibition was determined using a microcytotoxicity assay and apoptosis was measured as described in Mol Cancer Ther 7:2621 (2008). | B | 5.2 | pIC50 | 6300 | nM | IC50 | US-9320734-B2. Small molecule inhibitors of the pleckstrin homology domain and methods for using same (2016) |
AKT serine/threonine kinase 2 in Human [GtoPdb: 1480] [UniProtKB: P31751] | ||||||||
GtoPdb | Assay using purified recombinant pleckstrin homology domain of human Akt2 | - | 5.57 | pKi | 2670 | nM | Ki | Mol Cancer Ther (2010) 9: 706-17 [PMID:20197390] |
3-phosphoinositide dependent protein kinase 1 in Human [GtoPdb: 1519] [UniProtKB: O15530] | ||||||||
GtoPdb | Assay using purified recombinant pleckstrin homology domain of human PDK1 | - | 5.28 | pKi | 5200 | nM | Ki | Mol Cancer Ther (2010) 9: 706-17 [PMID:20197390] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]